Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S; DREAM investigators.
Diabetes Care. 2010 Oct;33(10):2250-3. Epub 2010 Jul 13.
Related citations
Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone.
RuaƱo G, Bernene J, Windemuth A, Bower B, Wencker D, Seip RL, Kocherla M, Holford TR, Petit WA, Hanks S.
Clin Chim Acta. 2009 Feb;400(1-2):48-55. Epub 2008 Oct 26.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on